Clinical Investigation on the Impact on Safety, Feasibility and Usability of the Design Changes Performed on ABLE Exoskeleton Device With Spinal Cord Injured Patients in a Hospital Setting

About this trial

This trial is enrolling individuals with traumatic and nontraumatic spinal cord injuries to test the safety and effect of a novel exoskeleton design (ABLE Exoskeleton) on gait and walking function. The ABLE is said to be lighter and more compact than existing exoskeleton devices. If included, participants will undergo a training program with the exoskeleton device two times a week for five weeks, for a total of 10 sessions. Final testing for walking function, general health and user satisfaction will be performed after 8 weeks.